Go Pro

Evommune (EVMN) Institutional Ownership

Evommune logo
$11.44 -0.78 (-6.35%)
Closing price 07/22/2026 03:59 PM Eastern
Extended Trading
$11.58 +0.13 (+1.14%)
As of 07/22/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Evommune (NYSE:EVMN)

Number of
Institutional Buyers
(last 12 months)
43
Total
Institutional Inflows
(last 12 months)
$426.89M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$8.28M
Get EVMN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Evommune stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

EVMN Institutional Buying and Selling by Quarter

Evommune Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/12/2026Defilade Capital Management L.P.678,589$15.60M2.2%+215.0%1.884%
5/29/2026Perceptive Advisors LLC448,350$10.31M0.2%N/A1.245%
5/19/2026Bank of America Corp DE30,201$694K0.0%+928.3%0.084%
5/19/2026Stempoint Capital LP193,777$4.39M0.8%+184.1%0.538%
5/19/2026Janus Henderson Group PLC896,700$20.62M0.0%N/A2.489%
5/18/2026Eversept Partners LP54,680$1.26M0.1%N/A0.152%
5/16/2026The Manufacturers Life Insurance Company 12,812$295K0.0%+25.3%0.036%
5/15/2026Octagon Capital Advisors LP143,472$3.30M0.4%-71.3%0.398%
5/14/2026Monashee Investment Management LLC179,340$4.12M2.2%-2.1%0.498%
5/5/2026Bank of New York Mellon Corp22,091$508K0.0%N/A0.061%
4/25/2026Strs Ohio1,800$41K0.0%N/A0.005%
2/18/2026XTX Topco Ltd18,778$321K0.0%N/A0.060%
2/18/2026Tudor Investment Corp ET AL31,953$547K0.0%N/A0.101%
2/18/2026Sphera Funds Management LTD.166,147$2.84M0.5%N/A0.527%
2/18/2026RTW Investments LP1,283,671$21.98M0.2%N/A4.073%
2/18/2026Oxford Asset Management LLP19,565$335K0.1%N/A0.062%
2/18/2026Balyasny Asset Management L.P.65,000$1.11M0.0%N/A0.206%
2/17/2026ADAR1 Capital Management LLC184,062$3.15M0.2%N/A0.584%
2/17/2026Burkehill Global Management LP50,000$856K0.1%N/A0.159%
2/17/2026MPM Bioimpact LLC113,022$1.94M0.2%N/A0.359%
2/17/2026RA Capital Management L.P.3,458,770$59.21M0.6%N/A10.973%
2/17/2026Price T Rowe Associates Inc. MD782,121$13.39M0.0%N/A2.481%
2/17/2026Integral Health Asset Management LLC125,000$2.14M0.1%N/A0.397%
2/16/2026Sofinnova Investments Inc.153,320$2.63M0.1%N/A0.486%
2/16/2026Verition Fund Management LLC565,214$9.68M0.0%N/A1.793%
2/16/2026NEXTBio Capital Management LP228,286$3.91M2.3%N/A0.724%
2/16/2026Nan Fung Group Holdings Ltd1,441,032$24.67M22.1%N/A4.572%
2/16/2026Eventide Asset Management LLC961,525$16.46M0.3%N/A3.051%
2/13/2026Marshall Wace LLP988,200$16.92M0.0%N/A3.135%
2/13/2026The Manufacturers Life Insurance Company 10,225$179K0.0%N/A0.032%
2/13/2026Pivotal bioVenture Partners Investment Advisor LLC1,926,943$32.99M12.8%N/A6.113%
2/13/2026Velan Capital Investment Management LP506,754$8.68M5.0%N/A1.608%
2/13/2026Charles Schwab Investment Management Inc.62,704$1.07M0.0%N/A0.199%
2/13/2026State Street Corp31,500$539K0.0%N/A0.100%
2/12/2026Federated Hermes Inc.325,000$5.56M0.0%N/A1.031%
2/12/2026SymBiosis Capital Partners LLC1,280,778$21.93M21.1%N/A4.063%
2/12/2026Monashee Investment Management LLC183,239$3.14M1.8%N/A0.581%
2/11/2026EQT Fund Management S.a r.l.4,929,633$84.40M7.6%N/A15.638%
2/11/2026JPMorgan Chase & Co.1,308,901$22.41M0.0%N/A4.152%
2/10/2026TD Asset Management Inc44,634$764K0.0%N/A0.142%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
2/10/2026Goldman Sachs Group Inc.61,675$1.06M0.0%N/A0.196%
2/10/2026Seven Grand Managers LLC75,000$1.28M0.1%N/A0.238%
2/9/2026Geode Capital Management LLC109,781$1.88M0.0%N/A0.348%
2/9/2026Sectoral Asset Management Inc.589,005$10.08M8.0%N/A1.869%
1/29/2026China Universal Asset Management Co. Ltd.2,000$34K0.0%N/A0.006%
1/21/2026Capricorn Fund Managers Ltd60,000$1.03M0.2%N/A0.190%


EVMN Institutional Ownership - Frequently Asked Questions

During the previous two years, 44 institutional investors and hedge funds held shares of Evommune. The most heavily invested institutionals were EQT Fund Management S.a r.l. ($84.40M), RA Capital Management L.P. ($59.21M), Pivotal bioVenture Partners Investment Advisor LLC ($32.99M), Nan Fung Group Holdings Ltd ($24.67M), JPMorgan Chase & Co. ($22.41M), RTW Investments LP ($21.98M), and SymBiosis Capital Partners LLC ($21.93M).Learn more on Evommune's institutional investors.

Of the 43 institutional investors that purchased Evommune's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: EQT Fund Management S.a r.l. ($4.93M), RA Capital Management L.P. ($3.46M), Pivotal bioVenture Partners Investment Advisor LLC ($1.93M), Nan Fung Group Holdings Ltd ($1.44M), JPMorgan Chase & Co. ($1.31M), RTW Investments LP ($1.28M), and SymBiosis Capital Partners LLC ($1.28M).

Institutional investors have bought a total of 24,185,662 shares in the last 24 months. This purchase volume represents approximately $426.89M in transactions.

The following institutional investors have sold Evommune stock in the last 24 months: Octagon Capital Advisors LP ($356.53K), and Monashee Investment Management LLC ($3.90K).

Institutional investors have sold a total of 360,427 shares in the last 24 months. This volume of shares sold represents approximately $8.28M in transactions.



This page (NYSE:EVMN) was last updated on 7/23/2026 by MarketBeat.com Staff.
From Our Partners